Membranous glomerulonephritis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
* The membranous | * The membranous glomerulonephritis is a rare disease.<ref name="McGroganFranssen2010">{{cite journal|last1=McGrogan|first1=A.|last2=Franssen|first2=C. F. M.|last3=de Vries|first3=C. S.|title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature|journal=Nephrology Dialysis Transplantation|volume=26|issue=2|year=2010|pages=414–430|issn=0931-0509|doi=10.1093/ndt/gfq665}}</ref><ref name="pmid28065518">{{cite journal |vauthors=Cattran DC, Brenchley PE |title=Membranous nephropathy: integrating basic science into improved clinical management |journal=Kidney Int. |volume=91 |issue=3 |pages=566–574 |date=March 2017 |pmid=28065518 |doi=10.1016/j.kint.2016.09.048 |url=}}</ref> | ||
===Incidence=== | ===Incidence=== | ||
*The incidence of membranous glomerulopathy is approximately 27 per 100,000 individuals worldwide.<ref name="McGroganFranssen2010">{{cite journal|last1=McGrogan|first1=A.|last2=Franssen|first2=C. F. M.|last3=de Vries|first3=C. S.|title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature|journal=Nephrology Dialysis Transplantation|volume=26|issue=2|year=2010|pages=414–430|issn=0931-0509|doi=10.1093/ndt/gfq665}}</ref> | *The incidence of membranous glomerulopathy is approximately 27 per 100,000 individuals worldwide.<ref name="McGroganFranssen2010">{{cite journal|last1=McGrogan|first1=A.|last2=Franssen|first2=C. F. M.|last3=de Vries|first3=C. S.|title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature|journal=Nephrology Dialysis Transplantation|volume=26|issue=2|year=2010|pages=414–430|issn=0931-0509|doi=10.1093/ndt/gfq665}}</ref> | ||
===Prevalence=== | ===Prevalence=== | ||
*The prevalence of membranous glomerulonephritis is approximately 690 per 100,000 individuals worldwide.<ref name="McGroganFranssen2010">{{cite journal|last1=McGrogan|first1=A.|last2=Franssen|first2=C. F. M.|last3=de Vries|first3=C. S.|title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature|journal=Nephrology Dialysis Transplantation|volume=26|issue=2|year=2010|pages=414–430|issn=0931-0509|doi=10.1093/ndt/gfq665}}</ref><ref name="pmid24715030" /> | *The prevalence of membranous glomerulonephritis is approximately 690 per 100,000 individuals worldwide.<ref name="McGroganFranssen2010">{{cite journal|last1=McGrogan|first1=A.|last2=Franssen|first2=C. F. M.|last3=de Vries|first3=C. S.|title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature|journal=Nephrology Dialysis Transplantation|volume=26|issue=2|year=2010|pages=414–430|issn=0931-0509|doi=10.1093/ndt/gfq665}}</ref><ref name="pmid24715030" /> | ||
===Mortality rate=== | ===Mortality rate=== | ||
*In 2001, the | *In 2001, the mortality rate of membranous glomerulonephritis is approximately 0.38%<ref name="McGroganFranssen2010" /><ref name="pmid24715030" /><ref name="pmid27365535">{{cite journal |vauthors=Xu X, Wang G, Chen N, Lu T, Nie S, Xu G, Zhang P, Luo Y, Wang Y, Wang X, Schwartz J, Geng J, Hou FF |title=Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China |journal=J. Am. Soc. Nephrol. |volume=27 |issue=12 |pages=3739–3746 |date=December 2016 |pmid=27365535 |pmc=5118492 |doi=10.1681/ASN.2016010093 |url=}}</ref> | ||
===Age=== | ===Age=== | ||
*Patients of all age groups may develop membranous glomerulonephritis | *Patients of all age groups may develop membranous glomerulonephritis | ||
*The incidence of | *The incidence of membranous glomerulonephritis increases with age; the median age at diagnosis is 40 years<ref name="TangYao2017">{{cite journal|last1=Tang|first1=Lijun|last2=Yao|first2=Jing|last3=Kong|first3=Xianglei|last4=Sun|first4=Qing|last5=Wang|first5=Zunsong|last6=Zhang|first6=Ying|last7=Wang|first7=Ping|last8=Liu|first8=Yipeng|last9=Li|first9=Wenbin|last10=Cui|first10=Meiyu|last11=Zhen|first11=Junhui|last12=Xu|first12=Dongmei|title=Increasing prevalence of membranous nephropathy in patients with primary glomerular diseases: A cross-sectional study in China|journal=Nephrology|volume=22|issue=2|year=2017|pages=168–173|issn=13205358|doi=10.1111/nep.12739}}</ref> | ||
===Race=== | ===Race=== | ||
* | *Membranous glomerulopathy usually affects individuals of the caucasian race and chinese population.<ref name="pmid24715030">{{cite journal |vauthors=Debiec H, Ronco P |title=Immunopathogenesis of membranous nephropathy: an update |journal=Semin Immunopathol |volume=36 |issue=4 |pages=381–97 |date=July 2014 |pmid=24715030 |doi=10.1007/s00281-014-0423-y |url=}}</ref><ref name="TangYao2017">{{cite journal|last1=Tang|first1=Lijun|last2=Yao|first2=Jing|last3=Kong|first3=Xianglei|last4=Sun|first4=Qing|last5=Wang|first5=Zunsong|last6=Zhang|first6=Ying|last7=Wang|first7=Ping|last8=Liu|first8=Yipeng|last9=Li|first9=Wenbin|last10=Cui|first10=Meiyu|last11=Zhen|first11=Junhui|last12=Xu|first12=Dongmei|title=Increasing prevalence of membranous nephropathy in patients with primary glomerular diseases: A cross-sectional study in China|journal=Nephrology|volume=22|issue=2|year=2017|pages=168–173|issn=13205358|doi=10.1111/nep.12739}}</ref> | ||
===Gender=== | ===Gender=== | ||
| Line 34: | Line 30: | ||
===Region=== | ===Region=== | ||
* Membranous glomerulonephritis tends to affect Caucasian population and Chinese population.<ref name="pmid24715030">{{cite journal |vauthors=Debiec H, Ronco P |title=Immunopathogenesis of membranous nephropathy: an update |journal=Semin Immunopathol |volume=36 |issue=4 |pages=381–97 |date=July 2014 |pmid=24715030 |doi=10.1007/s00281-014-0423-y |url=}}</ref><ref name="TangYao2017">{{cite journal|last1=Tang|first1=Lijun|last2=Yao|first2=Jing|last3=Kong|first3=Xianglei|last4=Sun|first4=Qing|last5=Wang|first5=Zunsong|last6=Zhang|first6=Ying|last7=Wang|first7=Ping|last8=Liu|first8=Yipeng|last9=Li|first9=Wenbin|last10=Cui|first10=Meiyu|last11=Zhen|first11=Junhui|last12=Xu|first12=Dongmei|title=Increasing prevalence of membranous nephropathy in patients with primary glomerular diseases: A cross-sectional study in China|journal=Nephrology|volume=22|issue=2|year=2017|pages=168–173|issn=13205358|doi=10.1111/nep.12739}}</ref> | * Membranous glomerulonephritis tends to affect Caucasian population and Chinese population.<ref name="pmid24715030">{{cite journal |vauthors=Debiec H, Ronco P |title=Immunopathogenesis of membranous nephropathy: an update |journal=Semin Immunopathol |volume=36 |issue=4 |pages=381–97 |date=July 2014 |pmid=24715030 |doi=10.1007/s00281-014-0423-y |url=}}</ref><ref name="TangYao2017">{{cite journal|last1=Tang|first1=Lijun|last2=Yao|first2=Jing|last3=Kong|first3=Xianglei|last4=Sun|first4=Qing|last5=Wang|first5=Zunsong|last6=Zhang|first6=Ying|last7=Wang|first7=Ping|last8=Liu|first8=Yipeng|last9=Li|first9=Wenbin|last10=Cui|first10=Meiyu|last11=Zhen|first11=Junhui|last12=Xu|first12=Dongmei|title=Increasing prevalence of membranous nephropathy in patients with primary glomerular diseases: A cross-sectional study in China|journal=Nephrology|volume=22|issue=2|year=2017|pages=168–173|issn=13205358|doi=10.1111/nep.12739}}</ref>\ | ||
==References== | ==References== | ||
Revision as of 21:25, 19 July 2018
|
Membranous glomerulonephritis Microchapters |
|
Differentiating Membranous glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Membranous glomerulonephritis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Membranous glomerulonephritis epidemiology and demographics |
|
FDA on Membranous glomerulonephritis epidemiology and demographics |
|
CDC on Membranous glomerulonephritis epidemiology and demographics |
|
Membranous glomerulonephritis epidemiology and demographics in the news |
|
Blogs on Membranous glomerulonephritis epidemiology and demographics |
|
Directions to Hospitals Treating Membranous glomerulonephritis |
|
Risk calculators and risk factors for Membranous glomerulonephritis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Ahsan Hussain, M.D.[2]
Overview
The incidence rate of membranous glomerulonephritis is 27 per 100.000. The prevalence rate of membranous glomerulonephritis is 690 per 100,000.
Epidemiology and Demographics
Incidence
- The incidence of membranous glomerulopathy is approximately 27 per 100,000 individuals worldwide.[1]
Prevalence
- The prevalence of membranous glomerulonephritis is approximately 690 per 100,000 individuals worldwide.[1][3]
Mortality rate
Age
- Patients of all age groups may develop membranous glomerulonephritis
- The incidence of membranous glomerulonephritis increases with age; the median age at diagnosis is 40 years[5]
Race
- Membranous glomerulopathy usually affects individuals of the caucasian race and chinese population.[3][5]
Gender
- Membranous glomerulonephritis affects men and women equally.[3]
Region
References
- ↑ 1.0 1.1 1.2 1.3 McGrogan, A.; Franssen, C. F. M.; de Vries, C. S. (2010). "The incidence of primary glomerulonephritis worldwide: a systematic review of the literature". Nephrology Dialysis Transplantation. 26 (2): 414–430. doi:10.1093/ndt/gfq665. ISSN 0931-0509.
- ↑ Cattran DC, Brenchley PE (March 2017). "Membranous nephropathy: integrating basic science into improved clinical management". Kidney Int. 91 (3): 566–574. doi:10.1016/j.kint.2016.09.048. PMID 28065518.
- ↑ 3.0 3.1 3.2 3.3 3.4 Debiec H, Ronco P (July 2014). "Immunopathogenesis of membranous nephropathy: an update". Semin Immunopathol. 36 (4): 381–97. doi:10.1007/s00281-014-0423-y. PMID 24715030.
- ↑ Xu X, Wang G, Chen N, Lu T, Nie S, Xu G, Zhang P, Luo Y, Wang Y, Wang X, Schwartz J, Geng J, Hou FF (December 2016). "Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China". J. Am. Soc. Nephrol. 27 (12): 3739–3746. doi:10.1681/ASN.2016010093. PMC 5118492. PMID 27365535.
- ↑ 5.0 5.1 5.2 Tang, Lijun; Yao, Jing; Kong, Xianglei; Sun, Qing; Wang, Zunsong; Zhang, Ying; Wang, Ping; Liu, Yipeng; Li, Wenbin; Cui, Meiyu; Zhen, Junhui; Xu, Dongmei (2017). "Increasing prevalence of membranous nephropathy in patients with primary glomerular diseases: A cross-sectional study in China". Nephrology. 22 (2): 168–173. doi:10.1111/nep.12739. ISSN 1320-5358.